ROCHE HOLDINGS AG SPN ADR EACH REP 0.125 GENUS (OTCi: RHHBY)

Overview
current price
$54.97
$54.97
change
-1.55 | -2.74%
-1.55 | -2.74%
Yesterday's Close
56.52
open
55.73
volume
3.30 M
30d. avg volume.
1.99 M
1 day
54.70 - 57.00
52 weeks
37.51 - 60.85
p/e
0.00
beta
0.4636
market cap
317.67 B
dividend yield
1.73%
Industry
-
News and Commentary
EU Eases Deportation Rules as Labor Shortages Threaten GDP And Unrest Fuels Political Pressure Europe has eased deportation rules of illegal migrants in response to rising public frustration over immigration, even as the region grows more dependent on foreign workers to of...
Microsoft Bets Big On Healthcare AI, Teams Up With Mayo Clinic Microsoft AI CEO Mustafa Suleyman said healthcare may be the most important use case for artificial intelligence as Microsoft Corp.
'Hair Loss With GLP-1s Is Real,' Ulta CEO Says As Weight Loss Drug Trend Boosts Hair, Skincare Sales Ulta Beauty Inc. (ULTA...
Trump Tariffs Forces AstraZeneca To Bring Substantial Pharmaceutical Production To US AstraZeneca plc (AZN&nb...
Pharma Industry Faces Jitters As Trump Hints At Historic Tariffs, BofA Outlines Probable Timeline U.S. President Donald Trump, on Tuesday, disclosed plans for a "major tariff" on foreign pharmaceuticals."We're going to be announcing very shortly a ma...
Diagnostic Giants Labcorp, Roche To Ramp Up Testing Capacity Amid Global Concerns Over New Mpox Stra... Labcorp Holdings Inc (LH...
Pfizer And Roche Advance On Their Weight Loss Drug Journeys After previously discounting a twice-daily version of its weight loss drug due to patients having difficulties tolerating it, Pfizer Inc
Roche Highlights Encouraging Data From Newly-Acquired Second Weight Loss Drug Candidate In Early-Sta... Wednesday, Roche Holdings AG (
AI Integration In Biotech & Pharma: Companies Positioned To Benefit The convergence of artificial intelligence (AI) with the biotech and pharmaceutical sectors is ushering in a new era of innovation. AI is catalyzing transformations from drug dis...
Biogen’s Alzheimer Drug Shows Promise in Key Study For the first time, a drug has been shown to
StockTwits
StockTwits

Join now and unlock premium features